New approach to stem cell transplantation may overcome immune rejection

Cell and organ transplants can be lifesaving, but patients often encounter long waiting lists due to the shortage of suitable donors.

AAO 2024: EyePoint’s EYP-1901 proves non-inferiority to aflibercept in DAVIO 2 – Pharmaceutical Technology

Image credit: Shutterstock/Drazen Zigic On 18 October, at the 128th Annual Meeting of the American Academy of Ophthalmology (AAO) 2024 in Chicago, clinical trial results

October 21, 2024

Failed trials for 16 IGF-1R inhibitors and $1.6B later: Time for better preclinical models?

New research published Friday in JAMA Network Open estimates that upwards of $50 billion to $60 billion is spent annually by biopharma companies on failed

August 1, 2023

Common Misconceptions About California’s New Psychedelics Bill

There is a lot of misinformation floating around online about SB-58, California’s newest psychedelics bill. Unlike the state’s last attempt, SB-58 went through both the

September 21, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.